Interpretation of Elevated Alpha-Fetoprotein

Clinical Significance

Nonseminomatous germ cell tumors are strongly associated with elevated AFP levels, and the National Comprehensive Cancer Network recommends thorough evaluation to rule out malignancy in adults with AFP >20 ng/ml 1, 2.
The approximate half-life of AFP is 5-7 days, making it useful for monitoring treatment response and detecting early relapse in testicular cancer, as suggested by the National Comprehensive Cancer Network 1.
Hepatoblastoma is strongly associated with elevated AFP, particularly in children with Beckwith-Wiedemann syndrome, and the American Cancer Society recommends regular AFP monitoring and abdominal ultrasound every 3 months through the child's fourth birthday 3.
Elevated maternal serum AFP is associated with open neural tube defects in the fetus, and the American College of Medical Genetics recommends confirmatory testing and genetic counseling 4, 5, 6, 7.

The National Comprehensive Cancer Network recommends radical inguinal orchiectomy and regular AFP monitoring for patients with testicular masses and elevated AFP 1, 2.
For children with overgrowth syndromes, the American Cancer Society recommends full abdominal ultrasound every 3 months through the child's fourth birthday and simultaneous serum AFP screening every 3 months 3.
When maternal serum AFP is elevated, the American College of Medical Genetics recommends confirmatory testing, repeat testing if elevation is minimal, and referral for level II ultrasound and genetic counseling 5, 7, 8.

AFP results should be interpreted in the context of patient age, clinical history, and symptoms, as well as trend over time rather than single values, according to the National Comprehensive Cancer Network and the American Cancer Society 1, 3.
The rate of decline after treatment is important in assessing treatment response, and small rises within reference ranges should not trigger additional testing, as suggested by the National Comprehensive Cancer Network and the American Cancer Society 1, 3.